Chemoinformaics analysis of 1,2,4,6-TETRA-O-GALLOYL-BETA-D-GLUCOSE
| Molecular Weight | 788.576 | nRot | 9 |
| Heavy Atom Molecular Weight | 760.352 | nRig | 34 |
| Exact Molecular Weight | 788.107 | nRing | 5 |
| Solubility: LogS | -2.22 | nHRing | 1 |
| Solubility: LogP | 1.561 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 4 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 84 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 56 | No. of Aromatic Carbocycles | 4 |
| nHetero | 22 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 28 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 34 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 24 |
| No. of Oxygen atom | 22 | No. of Arom Bond | 24 |
| nHA | 22 | APOL | 93.0942 |
| nHD | 13 | BPOL | 40.2418 |
| QED | 0.063 |
| Synth | 4.547 |
| Natural Product Likeliness | 0.84 |
| NR-PPAR-gamma | 0.54 |
| Lipinski | Rejected |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.153 |
| Pgp-sub | 0 |
| HIA | 0.996 |
| CACO-2 | -7.067 |
| MDCK | 0.00000921 |
| BBB | 0.004 |
| PPB | 0.831468 |
| VDSS | 0.394 |
| FU | 0.249643 |
| CYP1A2-inh | 0.382 |
| CYP1A2-sub | 0.009 |
| CYP2c19-inh | 0.011 |
| CYP2c19-sub | 0.017 |
| CYP2c9-inh | 0.32 |
| CYP2c9-sub | 0.017 |
| CYP2d6-inh | 0.001 |
| CYP2d6-sub | 0.07 |
| CYP3a4-inh | 0.023 |
| CYP3a4-sub | 0.002 |
| CL | 12.987 |
| T12 | 0.982 |
| hERG | 0.077 |
| Ames | 0.057 |
| ROA | 0 |
| SkinSen | 0.967 |
| Carcinogencity | 0.012 |
| EI | 0.937 |
| Respiratory | 0.001 |
| NR-Aromatase | 0.463 |
| Antiviral | Yes |
| Prediction | 0.791574 |